Mumps, Enders Strain

Mumps virus is a systemic viral disease of man. The most visibly apparent clinical symptom is demonstrated in two-thirds of infections, causing a characteristic swelling of salivary glands. Although other symptoms including sequela, meningioencephalitis, orchiditis leading to atrophy and some fetal wastage may be attributed to the disease. However, most cases are limited to nausea, vomiting, neck stiffness and headache. Control measures for mumps have been quite successful with the prevention of the disease through childhood vaccinations. Serological diagnosis of Mumps infection is the most common method of identification. Testing for the presence of Mumps antibody is a method of differentiating the disease from other parotitis-causing agents and to identify potential candidates for vaccination. \n\nSource: \nMumps virus, Enders strain, from LLC-MK2 cells.\n\nApplications:\nSuitable for use in ELISA. Other applications not tested.\n\nRecommended Dilution: \nOptimal dilutions to be determined by researcher.\n\nInactivation:\nGamma radiation inactivation.\n\nStorage and Stability:\nMay be stored at 4 degrees C for short-term only. For long-term storage, store at -70 degrees C. Aliquots are stable for at least 6 months at -70 degrees C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Prices direct from United States Biological

Quick response times

Exclusive Biosave savings/discounts